Finance

Lists
Why is 688105 down 2.90%?
Dive Deeper
688105:SHA
Nanjing Vazyme Biotech Co Ltd
CNÂ¥25.80
-2.90%
(-0.77) 1D
Sep 28, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688105...
Open
CNÂ¥26.99
High
CNÂ¥27.09
Low
CNÂ¥25.54
Mkt. cap
13.74B
Avg. vol.
14.78M
Volume
14.05M
Dividend
1.49%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
Jun 3, 2026
52-wk high
CNÂ¥28.30
52-wk low
CNÂ¥12.89
EPS
-CNÂ¥0.02
No. of employees
3K
Open
CNÂ¥26.99
High
CNÂ¥27.09
Low
CNÂ¥25.54
Mkt. cap
13.74B
Avg. vol.
14.78M
Volume
14.05M
Dividend
1.49%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
Jun 3, 2026
52-wk high
CNÂ¥28.30
52-wk low
CNÂ¥12.89
EPS
-CNÂ¥0.02
No. of employees
3K
About Nanjing Vazyme Biotech Co Ltd
CEO-
Employees3K
FoundedMar 16, 2012
Headquarters-
SectorBiotechnology
Websitevazyme.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
346.18M
425.48M
320.65M
379.80M
Cost of goods sold
93.31M
167.76M
92.87M
115.47M
Cost of revenue
93.31M
167.76M
92.87M
115.47M
Research and development expenses
71.34M
78.18M
67.69M
73.88M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
191.43M
208.11M
164.74M
184.25M
Operating expense
245.18M
323.26M
235.80M
258.56M
Total operating expenses
338.49M
491.02M
328.67M
374.03M
Operating income
7.70M
-65.54M
-8.02M
5.77M
Other non operating income
2.46M
-4.62M
132.05K
-11.51M
EBT including unusual items
-6.90M
-21.16M
-4.00M
413.22K
EBT excluding unusual items
5.30M
-64.66M
-8.78M
-2.73M
Income tax expense
-8.58M
5.06M
-5.99M
-3.44M
Effective tax rate
124.31%
-23.92%
149.67%
-832.56%
Other operating expenses
-13.76M
20.96M
3.29M
509.16K
Net income
3.49M
-23.23M
4.18M
6.78M
Net profit margin
1.01%
-5.46%
1.30%
1.79%
Earnings per share
-
-
-
-
Interest and investment income
7.60M
6.73M
5.27M
6.16M
Interest expense
-5.82M
-4.61M
-6.16M
-3.15M
Net interest expenses
1.79M
2.12M
-885.26K
3.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
31.56M
-42.56M
14.95M
31.92M
Gain or loss from assets sale
15.58K
293.68K
-
-454.41K
AI content may include mistakes. Learn more
Google apps